Mark Toland is a seasoned medical device veteran with over 20 years’ experience. Prior to joining Corindus, he served as Senior Vice President of Boston Scientific (BSC) where he led BSC's growth and market-innovation initiatives; directly managing corporate sales, marketing, commercial operations, and global solutions. Previously, Mark led BSC's Interventional Cardiology, Cardiac Rhythm Management, Peripheral Interventions, and Electrophysiology divisions, overseeing 2,000+ employees in sales, commercial operations, and customer service. In this role, Mark was accountable for over $4B in revenue and helped lead the integration efforts of key acquisitions, such as Guidant Corporation, Cameron Health (S-ICD), Bridgepoint Medical (CTO), and Watchman (LAAC) that has helped propel the company back to growth. Mark serves on numerous industry boards and has been a faculty member/speaker at numerous medical conferences. Mark holds a Bachelor of Business Administration and Marketing from the University of Louisville.